Nazli Dizman covers an update on the CBM588 probiotic strain and its phase II trial. Tom and Brian take a look back at the year in kidney cancer with Dr. Toni Choueiri. The Uromigos and Monty Pal discuss data on microbiome modification's impact on immune-oncology clinical efficacy in mRCC.